体成分对接受生物制剂治疗的活动性放射学阴性中轴型脊柱关节炎患者临床结局的影响
该研究纳入74例接受bDMARD治疗1年的放射学中轴型脊柱关节炎患者,采用生物电阻抗分析评估体成分。脂肪质量和脂肪质量指数与疾病活动度及功能残疾正相关,内脏脂肪与脊柱活动度下降相关;女性以疾病活动度和功能残疾关联为主,男性以脊柱活动度关联为主。
要点
- 脂肪质量及脂肪质量指数与ASDAS和BASFI正相关,脂肪质量指数与BASFI的β=0.125(95%CI 0.031–0.219)。
- 内脏脂肪与BASMI正相关(β=0.20,95%CI 0.07–0.33),提示与脊柱活动度下降相关。
- 女性中内脏脂肪和脂肪参数增加与更差疾病活动度和功能残疾相关,男性中与脊柱活动度下降强相关。
核心结论
- 在bDMARD治疗的放射学中轴型脊柱关节炎患者中,较高体脂和内脏脂肪与疾病活动度增加、功能残疾和脊柱活动度下降正相关。
研究设计与样本
- 德国脊柱关节炎起始队列(GESPIC)扩展研究,纳入74例放射学中轴型脊柱关节炎患者,基线为bDMARD候选者且既往非甾体抗炎药治疗下仍有高疾病活动度,基线及此后每6个月评估结局与体成分,采用纵向广义估计方程分析1年内关联。
主要发现
- 脂肪质量与ASDAS的β=0.012(95%CI -0.003–0.027),脂肪质量指数与ASDAS的β=0.035(95%CI -0.010–0.081)。
- 脂肪质量与BASFI的β=0.037(95%CI 0.004–0.070),脂肪质量指数与BASFI的β=0.125(95%CI 0.031–0.219)。
- 内脏脂肪与BASMI的β=0.20(95%CI 0.07–0.33)。
- 女性中内脏脂肪和脂肪参数增加与更差疾病活动度和功能残疾相关,男性中与脊柱活动度下降强相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the association of body composition (BC), evaluated by bioimpedance analysis (BIA), with disease activity, physical function and mobility in patients with axSpA undergoing bDMARD treatment for one year. METHODS: Patients with AS (radiographic axSpA) were enrolled in an extension of the German Spondyloarthritis Inception Cohort (GESPIC). Patients were required to be candidates for bDMARD therapy at baseline presenting high disease activity despite previous treatment with nonsteroidal anti-inflammatory drugs. Outcomes (disease activity, function and mobility) and BC parameters were assessed at baseline and every 6 months thereafter. The association between BC parameters and outcomes over 1 year was analysed using longitudinal generalized estimating equations. RESULTS: Seventy-four patients with radiographic axSpA were included in current analysis with a mean age of 36.5 years, disease duration of 6.2 years and Axial Spondyloarthritis Disease Activity Score (ASDAS) of 3.4 at baseline. Fat mass value and fat mass index were positively associated with disease activity (ASDAS: ß = 0.012, 95% CI [-0.003, 0.027] and ß = 0.035, 95% CI [-0.010, 0.081], respectively) and functional disability (BASFI: ß = 0.037, 95% CI [0.004, 0.070] and ß = 0.125, 95% CI [0.031, 0.219], respectively). Visceral adipose tissue (VAT) was associated with reduced spine mobility (BASMI: ß = 0.20, 95% CI [0.07, 0.33]). Additionally, increase in VAT and fat mass parameters was linked to worse disease activity and functional disability in women, while they were strongly associated with reduced spinal mobility in men. CONCLUSION: Higher levels of body fat and VAT were positively associated with increased disease activity, functional disability, and reduced spinal mobility in patients with radiographic axSpA treated with bDMARDs.
引用
- Rios Rodriguez V, Torgutalp M, Proft F, et al. Impact of body composition on clinical outcomes in patients with active radiographic axial spondyloarthritis under biological therapy. Rheumatology (Oxford). 2025. PMID: 38507706. doi:10.1093/rheumatology/keae133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。